251 related articles for article (PubMed ID: 11882817)
1. Molecular assessment of lymph nodes in patients with resected stage I non-small cell lung cancer: preliminary results of a prospective study.
Ahrendt SA; Yang SC; Wu L; Roig CM; Russell P; Westra WH; Jen J; Brock MV; Heitmiller RF; Sidransky D
J Thorac Cardiovasc Surg; 2002 Mar; 123(3):466-73; discussion 473-4. PubMed ID: 11882817
[TBL] [Abstract][Full Text] [Related]
2. Molecular staging of lung cancer: real-time polymerase chain reaction estimation of lymph node micrometastatic tumor cell burden in stage I non-small cell lung cancer--preliminary results of Cancer and Leukemia Group B Trial 9761.
D'Cunha J; Corfits AL; Herndon JE; Kern JA; Kohman LJ; Patterson GA; Kratzke RA; Maddaus MA
J Thorac Cardiovasc Surg; 2002 Mar; 123(3):484-91; discussion 491. PubMed ID: 11882819
[TBL] [Abstract][Full Text] [Related]
3. Adenocarcinoma of the pancreas: detection of occult metastases in regional lymph nodes by a polymerase chain reaction-based assay.
Demeure MJ; Doffek KM; Komorowski RA; Wilson SD
Cancer; 1998 Oct; 83(7):1328-34. PubMed ID: 9762933
[TBL] [Abstract][Full Text] [Related]
4. Comparison of oncogene mutation detection and telomerase activity for the molecular staging of non-small cell lung cancer.
Ahrendt SA; Yang SC; Wu L; Westra WH; Jen J; Califano JA; Sidransky D
Clin Cancer Res; 1997 Jul; 3(7):1207-14. PubMed ID: 9815801
[TBL] [Abstract][Full Text] [Related]
5. Lack of prognostic significance of p53 and K-ras mutations in primary resected non-small-cell lung cancer on E4592: a Laboratory Ancillary Study on an Eastern Cooperative Oncology Group Prospective Randomized Trial of Postoperative Adjuvant Therapy.
Schiller JH; Adak S; Feins RH; Keller SM; Fry WA; Livingston RB; Hammond ME; Wolf B; Sabatini L; Jett J; Kohman L; Johnson DH
J Clin Oncol; 2001 Jan; 19(2):448-57. PubMed ID: 11208838
[TBL] [Abstract][Full Text] [Related]
6. Multigene mutation analysis of metastatic lymph nodes in non-small cell lung cancer diagnosed by endobronchial ultrasound-guided transbronchial needle aspiration.
Nakajima T; Yasufuku K; Nakagawara A; Kimura H; Yoshino I
Chest; 2011 Nov; 140(5):1319-1324. PubMed ID: 21527506
[TBL] [Abstract][Full Text] [Related]
7. Prognostic Significance of the Number of Metastatic pN2 Lymph Nodes in Stage IIIA-N2 Non-Small-Cell Lung Cancer After Curative Resection.
Yoo C; Yoon S; Lee DH; Park SI; Kim DK; Kim YH; Kim HR; Choi SH; Kim WS; Choi CM; Jang SJ; Song SY; Kim SS; Choi EK; Lee JC; Suh C; Lee JS; Kim SW
Clin Lung Cancer; 2015 Nov; 16(6):e203-12. PubMed ID: 25997733
[TBL] [Abstract][Full Text] [Related]
8. Evaluation of p53 alterations in occult lymph node metastases.
Maruyama R; Sugio K; Fukuyama Y; Hamatake M; Sakada T; Saitoh G; Sugimachi K
J Surg Oncol; 2000 Mar; 73(3):143-7. PubMed ID: 10738267
[TBL] [Abstract][Full Text] [Related]
9. Time to refine N2 staging? cN2α and cN2β based on local regional involvement provide a more accurate prognosis in surgically treated IIIA non-small-cell lung cancer than N2 alone or the number of node stations involved.
Matsunaga T; Suzuki K; Takamochi K; Oh S
Eur J Cardiothorac Surg; 2014 Jul; 46(1):86-91. PubMed ID: 24321998
[TBL] [Abstract][Full Text] [Related]
10. Comparison of mutational changes in involved N1 lymph nodes with those in primary tumors in stage II non-small cell lung cancer: a pilot study.
Fernando HC; Sasatomi E; Christie NA; Buenaventura PO; Finkelstein SD; Yousem SA; Soose R; Close JM; Luketich JD
J Thorac Cardiovasc Surg; 2004 Jan; 127(1):87-91. PubMed ID: 14752417
[TBL] [Abstract][Full Text] [Related]
11. Molecular diagnosis and prognostic significance of lymph node micrometastasis in patients with histologically node-negative non-small cell lung cancer.
Dai CH; Li J; Yu LC; Li XQ; Shi SB; Wu JR
Tumour Biol; 2013 Apr; 34(2):1245-53. PubMed ID: 23355336
[TBL] [Abstract][Full Text] [Related]
12. [Comparative study for detecting micrometastases of lymph nodes in patients with lung cancer].
Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Tong XY
Zhonghua Yi Xue Za Zhi; 2008 Jan; 88(1):19-21. PubMed ID: 18346373
[TBL] [Abstract][Full Text] [Related]
13. Frequency and distribution of occult micrometastases in lymph nodes of patients with non-small-cell lung carcinoma.
Chen ZL; Perez S; Holmes EC; Wang HJ; Coulson WF; Wen DR; Cochran AJ
J Natl Cancer Inst; 1993 Mar; 85(6):493-8. PubMed ID: 7680382
[TBL] [Abstract][Full Text] [Related]
14. Immunoperoxidase staining for cytokeratins 8 and 18 is very sensitive for detection of occult node metastasis of colorectal cancer: a comparison with genetic analysis of K-ras.
Sasaki M; Watanabe H; Jass JR; Ajioka Y; Kobayashi M; Hatakeyama K
Histopathology; 1998 Mar; 32(3):199-208. PubMed ID: 9568504
[TBL] [Abstract][Full Text] [Related]
15. The impact of superior mediastinal lymph node metastases on prognosis in non-small cell lung cancer located in the right middle lobe.
Sakao Y; Okumura S; Mingyon M; Uehara H; Ishikawa Y; Nakagawa K
J Thorac Oncol; 2011 Mar; 6(3):494-9. PubMed ID: 21266920
[TBL] [Abstract][Full Text] [Related]
16. Number of metastatic lymph nodes in resected non-small cell lung cancer predicts patient survival.
Lee JG; Lee CY; Park IK; Kim DJ; Park SY; Kim KD; Chung KY
Ann Thorac Surg; 2008 Jan; 85(1):211-5. PubMed ID: 18154813
[TBL] [Abstract][Full Text] [Related]
17. Effect of number of lymph nodes sampled on outcome in patients with stage I non-small-cell lung cancer.
Gajra A; Newman N; Gamble GP; Kohman LJ; Graziano SL
J Clin Oncol; 2003 Mar; 21(6):1029-34. PubMed ID: 12637467
[TBL] [Abstract][Full Text] [Related]
18. Molecular detection of neoplastic cells in lymph nodes of metastatic colorectal cancer patients predicts recurrence.
Sanchez-Cespedes M; Esteller M; Hibi K; Cope FO; Westra WH; Piantadosi S; Herman JG; Jen J; Sidransky D
Clin Cancer Res; 1999 Sep; 5(9):2450-4. PubMed ID: 10499618
[TBL] [Abstract][Full Text] [Related]
19. [Clinicopathological study on nodal molecular staging of non-small-cell lung cancer].
Wang YX; Sun YE; Li XH; Wang ZB; Liu YL; Chen LA; Zhang GK
Zhonghua Yi Xue Za Zhi; 2007 Jan; 87(3):161-4. PubMed ID: 17425845
[TBL] [Abstract][Full Text] [Related]
20. Lymph node ratio predicts recurrence and survival after R0 resection for non-small cell lung cancer.
Taylor MD; LaPar DJ; Thomas CJ; Persinger M; Stelow EB; Kozower BD; Lau CL; Jones DR
Ann Thorac Surg; 2013 Oct; 96(4):1163-1170. PubMed ID: 23998409
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]